Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China · Delayed Price · Currency is CNY 22.26
+0.08 (0.36%)
Apr 30, 2026, 1:54 PM CST
SHA:688298 Market Cap
SHA:688298 has a market cap or net worth of 4.29 billion as of April 29, 2026. Its market cap has decreased by -15.76% in one year.
Market Cap
4.29B
Enterprise Value
2.13B
Revenue
947.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.26
Market Cap Chart
Since February 5, 2020, SHA:688298's market cap has decreased from 17.52B to 4.29B, a decrease of -75.54%. That is a compound annual growth rate of -20.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 4.29B | -5.34% |
| Dec 31, 2025 | 4.53B | -20.12% |
| Dec 31, 2024 | 5.67B | -21.40% |
| Dec 29, 2023 | 7.21B | -44.35% |
| Dec 30, 2022 | 12.95B | -53.17% |
| Dec 31, 2021 | 27.66B | 13.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou AGS MedTech | 4.99B |
| Shanghai Aohua Photoelectricity Endoscope | 4.97B |
| GKHT Medical Technology | 4.87B |
| Shanghai Kinetic Medical | 4.80B |
| Getein Biotech | 4.59B |
| Nanjing Medlander Medical Technology | 4.57B |
| Guangdong Biolight Meditech | 4.29B |
| Wuhan Easy Diagnosis Biomedicine | 3.79B |